Report cover image

Strategic Intelligence: Pharma M&A Deals Q3 2025 - Top Themes

Publisher GlobalData
Published Oct 29, 2025
SKU # GBDT20602026

Description

Strategic Intelligence: Pharma M&A Deals Q3 2025 - Top Themes

Summary

This report analyzes the disruptive themes that have driven M&A activity in Q3 2025 in the pharma Sector.

The global pharma sector in Q3 2025 witnessed deals worth $43 billion, a growth of 30% compared to Q3 2024. The Pharma sector recorded deal value worth $34 billion mega deals (defined as any deal valued at more than $1 billion) in Q3 2025, an increase of 67% compared to Q3 2024.

Scope
  • This report provides an overview of merger and acquisition activity globally in Q3 2025 in Pharma Sector
  • It identifies the themes driving most notable to deals announced in Q3 2025 in the Pharma Sector
Reasons to Buy
  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Table of Contents

Executive Summary
The Global FDI Narrative
Top Global FDI Hotspots in Q3 2025: Developed vs Developing Markets
The APAC FDI Narrative
Inward FDI Hotspots in APAC
Sectoral Disparities: Unpacking the Realities of Asia-Pacific’s FDI Activity
Top Investors
Appendices
Methodology
Contact us

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.